McKesson Corporat…

USUSD

McKesson Corporation (US:MCK) — Other Pharmaceuticals. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.

About the company

Website

mckesson.com

Investor relations

investor.mckesson.com/overview/default.aspx

Sector

Health Care · Other Pharmaceuticals

Headquarters

Irving, United States

Management

Brian S. Tyler

Kenny Cheung · EVP & Chief Financial Officer
LeAnn Smith · EVP & Chief Human Resources Officer
Michele Lau · EVP & Chief Legal Officer
Joan Eliasek · President, North American Pharmaceutical Distribution
Kevin Kettler · Executive Vice President, President, Prescription Technology Solutions
Kirk Kaminsky · Executive Vice President, Group President, North American Pharmaceutical Services
Jason Hammonds · President, Oncology & Multispecialty
Nimesh Jhaveri · EVP & Chief Impact Officer
Stanton McComb · President, Medical-Surgical
Francisco Fraga · EVP, Chief Information Officer and Chief Technology Officer

Latest reports

annual 2026 Form 10-K of 2026 Annual Report, PDF file, (opens in new window)

Employees

68 000

Founded

1833

IPO

1994-11-10

Shares outstanding

115.46 M as of 2026-10-30

Date	Shares	Change
30.10.2026	115.46 M	−1.0%	buyback
31.07.2026	116.59 M

Share count from the company reports. A split is detected by a jump in the count by a whole number of times.

Free float

116.39 M

Market cap

111.99 B USD

Insiders

0.06%

Institutions

93.45%

Industry (SIC)

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Legal form

XTIQ

ISIN

US58155Q1031

LEI

549300WZWOM80UCFSF54

P/E

26.8

Payout ratio

8.6%

FCF

6.42 B USD

Payout / FCF

Debt

9.73 B USD

0.7 y of FCF

Dividend streak

32 y

Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).

Net income

4.59 B USD 12 mo.

For the 12 months to 30.06.2026 (4 quarters)
Revenue	411 B USD
− Expenses	404 B USD
Gross profit	15.0 B USD
Net income	4.59 B USD

History by quarter

RevenueExpenses

09.202306.2026

Green above orange is profit (revenue − expenses); red below zero is a loss.

NAV

−36.37 USD

Balance sheet date	30.06.2026
Assets	88.3 B USD
− Liabilities	92.2 B USD
= Total equity	−3.86 B USD
− Non-controlling interests	376 M USD
= NAV (equity of the company's shareholders)	−4.24 B USD
− Goodwill	11.3 B USD
− Intangible assets	4.01 B USD
= Tangible NAV	−19.5 B USD
Shares	116 590 363
NAV per share	−36.37 USD
Tangible NAV per share	−168 USD

Equity is negative: liabilities exceed assets (often because of large share buybacks). P/NAV is not calculated.

NAV history

Balance sheet date	NAV	NAV per share
30.06.2026	−4.24 B USD	−36.37 USD
31.03.2026	−2.17 B USD	−18.07 USD
31.12.2025	−1.30 B USD	−10.60 USD
30.09.2025	−1.74 B USD	−14.09 USD
30.06.2025	−1.97 B USD	−15.81 USD
31.03.2025	−2.07 B USD	−16.58 USD
31.12.2024	−3.08 B USD	−24.61 USD
30.09.2024	−3.02 B USD	−23.77 USD

Description

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Exchanges and tickers

Exchange	Ticker	Currency	Price	Type
common stock
US USA Stocks	MCK primary	USD	999.62 +0.12%	common stock
LSE London Stock Exchange	0JZU IOB	USD	863.19 +0.00%	common stock
MX Mexican Stock Exchange	MCK secondary	MXN	16 610 +0.00%	common stock
depositary receipt
SA B3 Sao Paulo	M1CK34	BRL	72.31 -0.10%	depositary receipt

Price

D W M

Hover / tap a day — open, close, high and low prices

Candles

Each candle is one trading day. The thick part runs from the open price to the close price: green — the day closed higher than it opened, red — lower. The thin line runs from the lowest to the highest price of the day. Hover or tap a day to see all four prices.

Dividends

Orange dashed line «ex» — the ex-date: to receive the payment you must hold the shares before this day (shares bought on this day or later come without the dividend). On this day the price often drops by roughly the dividend amount. Blue dashed line «$» — the payment date. Future dates (up to 45 days) are shown on the right on a grey background.

P/E

The share price divided by the company earnings per share for the last 12 months (EPS). It shows how many years the company would need to earn its current profit to «pay back» the price: a lower P/E means the stock is cheaper relative to earnings. The line has its own scale on the left.

For some companies earnings come from their quarterly reports: on the day of a new report P/E jumps (a purple tick at the bottom of the chart), between reports it changes only with the price. For others P/E uses current earnings, so before the latest report it is approximate. If earnings are negative, P/E is not shown.

My position

Visible only to you and only if this stock is among your open portfolio positions (purchases in the same currency as the chart exchange). From each purchase date there is a dashed line at the purchase price, and between it and each day close price — an area: green if the position is in profit, red if at a loss. If you sold part, the remainder is shown: a sale writes off the earliest purchases first. The day tooltip shows how many shares were in the position and the gain or loss in money and %.

Payout yield

The blue dashed curve with its own % scale on the left: for each day — the last payment amount divided by that day close price. That is, what percentage of the share price one payment makes: the price rises — the percentage falls, and vice versa; when the company changes the payment, the curve moves to the new amount. The annual yield is roughly this percentage times the number of payments per year.

Above each «$» mark — the percentage of that payment relative to the price on the payment day (for future ones — relative to the last price, marked «≈»). Only payments in the chart exchange currency are counted.

Dividends

Next ex-date: 2026-12-01 · 0.94 USD (US:MCK)

Per year, US:MCK: 3.52 USD (4 paym.)

McKesson Corporation (MCK) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 3.52 USD per share (payments: 4). That is about 0.35% of the current share price. The next ex-dividend date is 01.12.2026: 0.94 USD per share, paid on 04.01.2027. Uninterrupted dividend history: 32 years.

Ordinary shares

Ex-date	Payment	Amount	%	Type	Ticker
2026-12-01 announced	2027-01-04	0.9400 USD	0.1/0.4 %	quarterly	US:MCK
2026-09-01	2026-10-01	0.9400 USD	0.1/0.4 %	quarterly	US:MCK
2026-06-01	2026-07-01	0.8200 USD	0.1/0.4 %	quarterly	US:MCK
2026-03-02	2026-04-01	0.8200 USD	0.1/0.3 %	quarterly	US:MCK
2025-12-01	2026-01-02	0.8200 USD	0.1/0.3 %	quarterly	US:MCK
2025-09-02	2025-10-01	0.8200 USD	0.1/0.4 %	quarterly	US:MCK
2025-06-02	2025-07-01	0.7100 USD	0.1/0.4 %	quarterly	US:MCK
2025-03-03	2025-04-01	0.7100 USD	0.1/0.4 %	quarterly	US:MCK
2024-12-02	2025-01-02	0.7100 USD	0.1/0.4 %	quarterly	US:MCK
2024-08-30	2024-10-01	0.7100 USD	0.1/0.3 %	quarterly	US:MCK
2024-06-03	2024-07-01	0.6200 USD	0.1/0.2 %	quarterly	US:MCK
2024-02-29	2024-04-01	0.6200 USD	0.1/0.2 %	quarterly	US:MCK
2023-11-30	2024-01-02	0.6200 USD	0.1/0.2 %	quarterly	US:MCK
2023-08-31	2023-10-02	0.6200 USD	0.1/0.2 %	quarterly	US:MCK
2023-05-31	2023-07-03	0.5400 USD	0.1/0.2 %	quarterly	US:MCK
2023-02-28	2023-04-03	0.5400 USD	0.1/0.2 %	quarterly	US:MCK
2022-11-30	2023-01-03	0.5400 USD	0.1/0.2 %	quarterly	US:MCK
2022-08-31	2022-10-03	0.5400 USD	0.1/0.2 %	quarterly	US:MCK
2022-05-31	2022-07-01	0.4700 USD	0.0/0.1 %	quarterly	US:MCK
2022-02-28	2022-04-01	0.4700 USD	0.0/0.1 %	quarterly	US:MCK
2021-11-30	2022-01-03	0.4700 USD	0.0/0.0 %	quarterly	US:MCK

Depositary receipts

Ex-date	Payment	Amount	%	Type	Ticker
2026-08-31	—	0.052062 BRL	0.1/0.3 %	regular	SA:M1CK34
2026-05-29	—	0.046583 BRL	0.1/0.3 %	regular	SA:M1CK34
2026-02-27	—	0.046323 BRL	0.1/0.3 %	regular	SA:M1CK34
2025-11-28	—	0.048741 BRL	0.1/0.3 %	regular	SA:M1CK34
2025-09-01	—	0.047932 BRL	0.1/0.3 %	regular	SA:M1CK34
2025-05-30	—	0.042327 BRL	0.1/0.3 %	regular	SA:M1CK34
2025-02-27	—	0.0442 BRL	0.1/0.3 %	regular	SA:M1CK34
2024-11-29	—	0.047801 BRL	0.1/0.3 %	regular	SA:M1CK34
2024-08-30	—	0.042167 BRL	0.1/0.3 %	regular	SA:M1CK34
2024-05-31	—	0.03843 BRL	0.1/0.2 %	regular	SA:M1CK34
2024-02-29	—	0.034226 BRL	0.0/0.2 %	regular	SA:M1CK34
2023-11-30	—	0.033369 BRL	0.0/0.2 %	regular	SA:M1CK34
2023-08-31	—	0.034635 BRL	0.0/0.2 %	regular	SA:M1CK34
2023-05-31	—	0.042314 BRL	0.1/0.2 %	regular	SA:M1CK34
2023-02-28	—	0.042825 BRL	0.1/0.2 %	regular	SA:M1CK34
2022-11-30	—	0.045945 BRL	0.1/0.2 %	regular	SA:M1CK34
2022-08-31	—	0.043373 BRL	0.1/≈0.2 %	regular	SA:M1CK34
2022-05-31	—	0.039578 BRL	0.1/≈0.2 %	regular	SA:M1CK34
2022-02-24	—	0.033906 BRL	0.0/≈0.1 %	regular	SA:M1CK34
2021-11-30	—	0.041691 BRL	0.1/≈0.1 %	regular	SA:M1CK34

Top holders

Holder	Stake	Shares	Report date
Blackrock Inc.	9.26%	10.8 M	2026-06-30
Vanguard Capital Managem…	6.74%	7.85 M	2026-06-30
State Street Corporation	4.91%	5.73 M	2026-06-30
Morgan Stanley	4.55%	5.31 M	2026-06-30
VANGUARD INDEX FUNDS-Van…	3.27%	3.82 M	2026-06-30
VANGUARD INDEX FUNDS-Van…	2.67%	3.11 M	2026-06-30
Franklin Resources, Inc.	2.49%	2.91 M	2026-06-30
Vanguard Portfolio Manag…	2.46%	2.87 M	2026-06-30
Geode Capital Management…	2.42%	2.82 M	2026-06-30
Massachusetts Financial…	2.1%	2.45 M	2026-06-30
FMR, LLC	1.83%	2.13 M	2026-06-30
JPMORGAN CHASE & CO	1.5%	1.75 M	2026-06-30
iShares Trust-iShares Co…	1.37%	1.6 M	2026-08-31
MFS SERIES TRUST I-MFS V…	1.34%	1.57 M	2026-05-31
Fidelity Concord Street…	1.33%	1.55 M	2026-07-31
SPDR S&P 500 ETF TRUST-S…	1.26%	1.47 M	2026-08-31
VANGUARD INDEX FUNDS-Van…	0.98%	1.14 M	2026-06-30
PUTNAM LARGE CAP VALUE F…	0.98%	1.14 M	2026-07-31
SELECT SECTOR SPDR TRT-S…	0.74%	864 018	2026-08-31
VANGUARD SPECIALIZED FUN…	0.58%	680 107	2026-07-31
VITALONE BRITT J (Chief…	≈0.02%	22 505	2026-05-22
FRAGA FRANCISCO (Chief T…	≈0.01%	6 210	2026-05-22
TYLER BRIAN SCOTT (Chief…	≈0.01%	6 134	2026-07-07
SMITH LEANN B (Officer)	≈0%	4 798	2026-06-01
LAU MICHELE (Officer)	≈0%	3 386	2026-05-26
RODGERS THOMAS L (Office…	≈0%	2 268	2026-06-02
CARUSO DOMINIC J (Direct…	≈0%	927	2026-07-22
MARTINEZ MARIA N. (Direc…	≈0%	578	2026-07-22
WILSON - THOMPSON KATHLE…	≈0%	578	2026-07-22
RUTLEDGE NAPOLEON B JR (…	≈0%	521	2026-09-08
The Vanguard Group	—	—	—
Capital Group Companies	—	—	—
Wellington Management Co…	—	—	—